-

Northlane Capital Partners Invests in VMG Health

BETHESDA, Md.--(BUSINESS WIRE)--Northlane Capital Partners (“NCP”) announced today that it has made an investment in VMG Health (“VMG”), a leading full-service valuation and transaction advisory firm exclusively focused on the healthcare industry. NCP invested in partnership with VMG’s existing management team and key employees, led by Founder and CEO Greg Koonsman.

Founded in 1995, VMG Health provides compliance related transaction services including: business, real estate, and asset valuation, physician compensation plan design and valuation, buy side and sell side quality of earnings, litigation and dispute services, and reimbursement consulting. Additional information is available at www.vmghealth.com.

“I am thrilled that we have entered into a partnership with Northlane Capital Partners to continue our firm’s legacy of healthcare transaction expertise. We share a vision with NCP for the next phase of our company as the market leader in healthcare valuation, diligence services, and consulting. Our singular focus in healthcare allows us to differentiate our core services of healthcare business and real estate related valuation, quality of earnings and diligence, physician compensation consulting and valuation, and reimbursement related consulting. Now in our 25th year, we will continue to build the VMG Health brand which has been synonymous with expertise, quality, and responsiveness to our customers,” said Greg Koonsman, Founder and CEO of VMG.

Eugene Krichevsky, Partner at NCP, noted, “VMG is the clear leader in a niche within the healthcare sector where we can utilize our industry expertise and network to help create value. We look forward to working alongside Greg and the VMG team to continue to broaden VMG’s capabilities and customer base, both through organic growth initiatives and the acquisition of complementary service lines.”

Sean Eagle, Partner at NCP, added, “We are very excited to partner with VMG. The company’s compelling value proposition and best in class team, coupled with the continuously evolving healthcare regulatory landscape, provide a strong foundation for future growth.”

ABOUT NORTHLANE CAPITAL PARTNERS

Based in Bethesda, MD, Northlane Capital Partners is a private equity firm focused on key segments within the healthcare and business services sectors, where its principals have invested $1.5 billion of equity capital. NCP seeks investments in middle market companies based in North America with EBITDA of $5 million to $30 million. NCP’s strategy is to partner with industry leading companies and great management teams, aligning incentives to accelerate growth and build value. For more information, please visit www.northlanecapital.com.

Contacts

Eugene Krichevsky, Partner
(301) 841-1399

Sean Eagle, Partner
(301) 841-1377

JJ Carbonell, Vice President
(301) 841-1420

Northlane Capital Partners


Release Versions

Contacts

Eugene Krichevsky, Partner
(301) 841-1399

Sean Eagle, Partner
(301) 841-1377

JJ Carbonell, Vice President
(301) 841-1420

More News From Northlane Capital Partners

Northlane Capital Partners Announces Investment in Plus Delta Partners

CARLSBAD, Calif.--(BUSINESS WIRE)--Northlane Capital Partners (“NCP”) announced today that it has made an investment in Plus Delta Partners (“PDP”), a leading provider of specialized fundraising training and tools designed to enable higher education institutions, healthcare organizations, and other nonprofits to maximize donor contributions. NCP invested alongside PDP’s management team and its founder, Guy Hart. PDP offers a comprehensive suite of fundraising training solutions tailored to fron...

Northlane Capital Partners Invests in United States Drug Testing Laboratories

DES PLAINES, Ill.--(BUSINESS WIRE)--Northlane Capital Partners (“NCP”) announced today that it has invested in United States Drug Testing Laboratories Inc. (“USDTL”), a forensic toxicology laboratory testing for alcohol and substance use. NCP invested alongside USDTL’s management team and its founders, Veronica and Doug Lewis. USDTL is headquartered in Des Plaines, IL, and offers a broad suite of forensic testing capabilities. The company primarily serves hospitals, health systems, court system...

SAI MedPartners Expands Strategic Service Offering Through Acquisition of IDEA Pharma

READING, Pa.--(BUSINESS WIRE)--SAI MedPartners (“SAI”), a global consultancy providing strategic insights and analytics to the pharmaceutical, biotechnology, and medical device industries, is pleased to announce that it has acquired IDEA Pharma (“IDEA”). Northlane Capital Partners (“NCP”) partnered with management to acquire SAI in June 2022. IDEA, headquartered in London, United Kingdom, specializes in pharmaceutical path-to-market strategy and innovation. This acquisition strengthens SAI’s ca...
Back to Newsroom